A new nitrobenzoxadiazole-based GSTP1-1 inhibitor with a previously unheard of mechanism of action and high stability.
J Enzyme Inhib Med Chem
; 32(1): 240-247, 2017 Dec.
Article
en En
| MEDLINE
| ID: mdl-28097896
ABSTRACT
CONTEXT The nitrobezoxadiazole derivative NBDHEX is a potent inhibitor of glutathione transferase P1-1 (GSTP1-1) endowed with outstanding anticancer activity in different tumor models. OBJECTIVE:
To characterize by in vitro biochemical and in silico studies the NBDHEX analogues named MC2752 and MC2753. MATERIALS ANDMETHODS:
Synthesis of MC2752 and MC2753, biochemical assays and in silico docking and normal-mode analyses.RESULTS:
The presence of a hydrophobic moiety in the side chain of MC2753 confers unique features to this molecule. Unlike its parent drug NBDHEX, MC2753 does not require GSH to trigger the dissociation of the complex between GSTP1-1 and TRAF2, and displays high stability towards the nucleophilic attack of the tripeptide under physiological conditions. DISCUSSION ANDCONCLUSION:
MC2753 may represent a lead compound for the development of novel GSTP1-1 inhibitors not affected in their anticancer action by fluctuations of cellular GSH levels, and characterized by an increased half-life in vivo.Palabras clave
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Oxazoles
/
Inhibidores Enzimáticos
/
Gutatión-S-Transferasa pi
Límite:
Humans
Idioma:
En
Revista:
J Enzyme Inhib Med Chem
Asunto de la revista:
BIOQUIMICA
/
QUIMICA
Año:
2017
Tipo del documento:
Article
País de afiliación:
Italia